首页> 外文期刊>Viral immunology >HPV18 E1 Protein Plus α-Galactosylceramide Elicit in Mice CD8~+ T Cell Cross-Reactivity Against Cells Expressing E1 from Diverse Human Papillomavirus Types
【24h】

HPV18 E1 Protein Plus α-Galactosylceramide Elicit in Mice CD8~+ T Cell Cross-Reactivity Against Cells Expressing E1 from Diverse Human Papillomavirus Types

机译:HPV18 E1蛋白加上α-半乳糖基酰胺在小鼠CD8〜+ T细胞交叉反应中,对来自不同人乳头瘤病毒类型表达E1的细胞

获取原文
获取原文并翻译 | 示例
           

摘要

CD8~+ T cell immune response plays a critical role in the clearance of human papillomavirus (HPV)-infected cells. During the natural history of HPV infection, the E1 protein, an early-expressed helicase highly conserved among papillomaviruses, is involved in the replication of HPV genomes. We have previously shown, in a murine model, that immunization with HPV 18 E1 protein combined with α-galactosylceramide elicits a specific CD8~+ T cell response. We further proved those findings by analyzing whether CD8~+ T cells from mice immunized with α-galactosylceramide plus HPV18 E1 protein could have a cytotoxic effect on cells expressing the carboxyl-terminal domain from the E1 proteins of other HPV types. Interestingly, CD8~+ T cells raised against HPV 18 E1 antigen presented cross-reactivity against the E1 protein from HPV53, 33, 16, and 31. Poor cross-reactivity was observed for HPV11, and none for HPV6. This outcome may be relevant for the design of broad-spectrum immune-protective agents against HPV infections.
机译:CD8〜+ T细胞免疫应答在人乳头瘤病毒(HPV) - 培养的细胞的间隙中起着关键作用。在HPV感染的自然历史中,E1蛋白是乳头瘤病毒高度保守的早期螺旋酶,参与了HPV基因组的复制。我们之前已经显示在鼠模型中,用HPV 18 E1蛋白与α-半乳糖基胺的免疫引发特定的CD8〜+ T细胞反应。我们通过分析来自用α-半乳糖基胺加HPV18 E1蛋白免疫的小鼠的CD8〜+ T细胞的CD8〜+ T细胞进一步证明了这些发现可能对表达来自其他HPV类型的E1蛋白的羧基 - 末端结构域的细胞具有细胞毒性作用。有趣的是,针对HPV 18 E1抗原提出的CD8〜+ T细胞对来自HPV53,33,16和31的E1蛋白呈现的交叉反应性。对于HPV11观察到差的交叉反应性,没有用于HPV6。该结果可能与抗HPV感染的广谱免疫保护剂的设计相关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号